France: In a Medicare population with inflammatory bowel disease (IBD), treatment with immunomodulators or biologics was not ...
Treatment to heal the lining of the gastrointestinal tract is an increasingly common goal for inflammatory bowel disease ...
Multiple intramolecular switches among anti-TNF agents in children with inflammatory bowel disease show no clinically ...
Wearable device-derived sleep metrics may help monitor inflammatory bowel disease activity and response to biologic therapy, ...
For women with inflammatory bowel disease (IBD), pregnancy is already high-stakes -- and conflicting medical advice worldwide has only added to the uncertainty. Now, a global team of specialists and ...
MRM Health, a clinical-stage biopharmaceutical company developing therapeutics for immune-mediated diseases, which unlock the ...
A stem cell-derived intestine model reveals glycyrrhizin as a potential treatment for inflammatory bowel disease.
Eli Lilly and Co.’s approval for Omvoh to treat moderate to severe Crohn’s disease in adults marks the Indianapolis company’s growing presence in the treatment of inflammatory bowel disease. This ...
Real‑world and prospective data demonstrate the role of clearance‑informed, precision‑guided dosing in supporting individualized treatment decisions and durable disease control SAN DIEGO, CA / ACCESS ...
Patients with inflammatory bowel disease often have to wait a long time to find the right medicine. But the methods of a large interdisciplinary research team offer hope. IBD is the common ...
Navigating social events with IBD doesn’t mean choosing between fitting in and feeling well.